Since different CD133 clones have been used in previous studies of AML and CRC [19,20], revealing different CD133 binding patterns, we compared the most common clones AC133, W6B3C1, and 293C3 in B-ALL. This evidence concerns the gene PROM1 and acute lymphoblastic leukemia.